Amniotic Membranes Market Competitive Insights and Precise Outlook through 2028

 In 2022, the global Amniotic Membranes Market is expected to be worth approximately US$ 1.4 billion. Furthermore, with the increasing use of amniotic membranes in ophthalmology, total sales of amniotic membranes are expected to grow at a CAGR of 9.0% between 2022 and 2028, reaching more than US$ 2.3 Billion by the end of 2028.

Population of all age groups has emerged as a prominent consumer base, characterized by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries.

For more information @ https://www.futuremarketinsights.com/reports/amniotic-membrane-market

This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic with regard to increasing amniotic membrane transplants and increasing demand for amniotic membrane products around the world, particularly in North American countries.

It is more than likely that over the span of the next four to five years, the companies focus on developing innovative products and designing market level strategies to leverage the potential opportunities emerging in parallel with growing human population with various chronic diseases.

Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membrane and lyophilized amniotic membrane have evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.

Some of the key points identified in global amniotic membrane market are:

• FMI forecasts the global amniotic membrane market to grow at a CAGR of 9.3% over the forecast period by 2028 end. The growth in revenue generation across the amniotic membrane market is registered on the account of rise in amniotic membrane transplants in both developed and developing economies.
• The hospitals segment has proved to be the leading end user segment on account of increase in number of amniotic membrane transplants, growing awareness among the people about the benefits of the amniotic membrane transplant.
• Ease of FDA approval for novel and innovative amniotic membrane allografts coupled with adoption of amniotic membrane for varied applications would boost the revenue growth in Germany & the U.S. markets.
• Most often, apart from major applications including surgical wound and ophthalmology, the use of amniotic tissue in orthopaedic surgery, sports medicine and podiatry treatment has increased in the recent years.
• The amniotic membranes used majorly to treat human surgical wound needs to be FDA approved, thus amniotic membrane manufacturers focus on getting fast FDA approvals.

Key companies profiled:

Integra LifeSciences Inc., MiMedx Group, Inc., Tissue-Tech Inc., Skye Biologics Inc., Katena Products Inc., Alliqua BioMedical Inc., Human Regenerative Technologies LLC, Amnio Technology LLC, Applied Biologics LLC

Key Segments Of Amniotic Membranes Market Industry Survey

Amniotic Membranes Market by Product Type:

• Cryopreserved Amniotic Membranes
• Lyophilized Amniotic Membranes

Amniotic Membranes Market by Application:

• Surgical Wounds
• Ophthalmology
• Others

Amniotic Membranes Market by End User:

• Hospitals
• Specialized Clinics
• Ambulatory Surgical Centres
• Academic Research Centres